Hiroshi Mashimo, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Barrett Esophagus | 24 | 2023 | 492 | 4.600 |
Why?
|
| Esophagus | 14 | 2020 | 1033 | 2.700 |
Why?
|
| Esophagoscopy | 16 | 2020 | 396 | 2.450 |
Why?
|
| Esophageal Neoplasms | 19 | 2023 | 1654 | 2.220 |
Why?
|
| Tomography, Optical Coherence | 22 | 2020 | 2917 | 2.120 |
Why?
|
| Precancerous Conditions | 8 | 2018 | 980 | 1.780 |
Why?
|
| Esophagogastric Junction | 11 | 2020 | 347 | 1.550 |
Why?
|
| Gastroesophageal Reflux | 9 | 2023 | 819 | 1.520 |
Why?
|
| Adenocarcinoma | 16 | 2023 | 6346 | 1.090 |
Why?
|
| Endoscopy, Gastrointestinal | 4 | 2015 | 874 | 1.010 |
Why?
|
| Enteric Nervous System | 3 | 2019 | 212 | 0.970 |
Why?
|
| Catheter Ablation | 10 | 2017 | 2751 | 0.900 |
Why?
|
| Esophageal Sphincter, Lower | 3 | 2020 | 26 | 0.900 |
Why?
|
| Radiation Injuries | 3 | 2019 | 1189 | 0.890 |
Why?
|
| Proctitis | 3 | 2014 | 41 | 0.870 |
Why?
|
| Angiography | 4 | 2019 | 1595 | 0.870 |
Why?
|
| Nitric Oxide Synthase | 9 | 2005 | 908 | 0.830 |
Why?
|
| Esophageal Diseases | 2 | 2012 | 168 | 0.740 |
Why?
|
| Gastric Emptying | 3 | 2019 | 242 | 0.710 |
Why?
|
| Stomach Neoplasms | 8 | 2018 | 1459 | 0.640 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2013 | 1250 | 0.630 |
Why?
|
| Rectal Diseases | 1 | 2019 | 143 | 0.590 |
Why?
|
| Microvessels | 2 | 2019 | 577 | 0.580 |
Why?
|
| Proton Pump Inhibitors | 4 | 2020 | 532 | 0.570 |
Why?
|
| Stomach | 4 | 2015 | 696 | 0.500 |
Why?
|
| Oxyphil Cells | 1 | 2015 | 56 | 0.500 |
Why?
|
| Stem Cells | 4 | 2015 | 3522 | 0.490 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2014 | 4063 | 0.480 |
Why?
|
| Ki-67 Antigen | 2 | 2015 | 629 | 0.480 |
Why?
|
| Histamine Antagonists | 1 | 2013 | 92 | 0.430 |
Why?
|
| Fundoplication | 4 | 2020 | 144 | 0.430 |
Why?
|
| Metaplasia | 7 | 2018 | 322 | 0.420 |
Why?
|
| Endoscopy, Digestive System | 2 | 2012 | 351 | 0.410 |
Why?
|
| Choristoma | 1 | 2012 | 206 | 0.350 |
Why?
|
| Microcirculation | 1 | 2014 | 1273 | 0.330 |
Why?
|
| Gastric Mucosa | 2 | 2012 | 604 | 0.320 |
Why?
|
| Radiotherapy | 2 | 2014 | 1499 | 0.310 |
Why?
|
| Mucins | 3 | 2015 | 568 | 0.300 |
Why?
|
| Gastrointestinal Motility | 5 | 2019 | 234 | 0.300 |
Why?
|
| Intestinal Mucosa | 7 | 2009 | 3032 | 0.300 |
Why?
|
| Rectum | 2 | 2019 | 892 | 0.290 |
Why?
|
| Hirschsprung Disease | 1 | 2009 | 163 | 0.280 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2014 | 1116 | 0.280 |
Why?
|
| Nitric Oxide Synthase Type I | 8 | 2008 | 174 | 0.270 |
Why?
|
| Endoscopy | 2 | 2015 | 1851 | 0.250 |
Why?
|
| Health | 1 | 2008 | 398 | 0.250 |
Why?
|
| Cardia | 2 | 2018 | 60 | 0.240 |
Why?
|
| Neural Inhibition | 3 | 2007 | 590 | 0.230 |
Why?
|
| Neurotransmitter Agents | 2 | 1999 | 665 | 0.220 |
Why?
|
| Growth Substances | 2 | 1996 | 768 | 0.220 |
Why?
|
| Esophageal Motility Disorders | 1 | 2023 | 49 | 0.210 |
Why?
|
| Neurons | 3 | 2019 | 9463 | 0.210 |
Why?
|
| Nitric Oxide | 5 | 2008 | 2135 | 0.200 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2010 | 954 | 0.200 |
Why?
|
| Muscle Relaxation | 3 | 2011 | 138 | 0.200 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 1263 | 0.190 |
Why?
|
| Microscopy, Confocal | 3 | 2020 | 1971 | 0.190 |
Why?
|
| Humans | 61 | 2023 | 761504 | 0.180 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 1600 | 0.180 |
Why?
|
| Muscle Proteins | 2 | 1996 | 1154 | 0.180 |
Why?
|
| Manometry | 3 | 2020 | 454 | 0.180 |
Why?
|
| Lymphatic Metastasis | 3 | 2018 | 2915 | 0.170 |
Why?
|
| Neuropeptides | 2 | 1996 | 944 | 0.170 |
Why?
|
| Gastrointestinal Tract | 3 | 2017 | 833 | 0.170 |
Why?
|
| China | 6 | 2015 | 2369 | 0.170 |
Why?
|
| Heartburn | 1 | 2019 | 68 | 0.170 |
Why?
|
| Motilin | 1 | 2019 | 3 | 0.170 |
Why?
|
| Capsule Endoscopy | 1 | 2020 | 100 | 0.170 |
Why?
|
| Image Enhancement | 2 | 2007 | 2885 | 0.170 |
Why?
|
| Hernia, Hiatal | 1 | 2020 | 90 | 0.170 |
Why?
|
| DNA | 1 | 2013 | 7212 | 0.160 |
Why?
|
| Proctoscopy | 1 | 2019 | 40 | 0.160 |
Why?
|
| Omeprazole | 1 | 2019 | 105 | 0.160 |
Why?
|
| Carcinoma | 3 | 2015 | 2330 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type II | 5 | 2005 | 517 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type III | 6 | 2007 | 705 | 0.160 |
Why?
|
| Immunohistochemistry | 7 | 2015 | 11076 | 0.150 |
Why?
|
| Mucous Membrane | 2 | 2013 | 659 | 0.150 |
Why?
|
| Peptides | 3 | 2008 | 4358 | 0.140 |
Why?
|
| Ghrelin | 1 | 2019 | 252 | 0.140 |
Why?
|
| H-2 Antigens | 4 | 1992 | 357 | 0.140 |
Why?
|
| Gastric Fundus | 1 | 1996 | 37 | 0.140 |
Why?
|
| Keratin-7 | 1 | 2015 | 55 | 0.130 |
Why?
|
| Keratin-5 | 1 | 2015 | 45 | 0.130 |
Why?
|
| Colonic Polyps | 1 | 2020 | 554 | 0.130 |
Why?
|
| Aged | 20 | 2020 | 169289 | 0.130 |
Why?
|
| Male | 34 | 2023 | 360804 | 0.120 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 58976 | 0.120 |
Why?
|
| Muramidase | 1 | 2015 | 169 | 0.120 |
Why?
|
| Epithelium | 3 | 2015 | 1603 | 0.120 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 145 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 3 | 2005 | 4414 | 0.120 |
Why?
|
| Cell Transdifferentiation | 1 | 2015 | 185 | 0.120 |
Why?
|
| Disease Progression | 6 | 2017 | 13506 | 0.110 |
Why?
|
| Biopsy | 3 | 2020 | 6766 | 0.110 |
Why?
|
| Synaptic Transmission | 2 | 1999 | 1173 | 0.110 |
Why?
|
| Treatment Outcome | 11 | 2019 | 64680 | 0.110 |
Why?
|
| Chronic Disease | 3 | 2019 | 9318 | 0.110 |
Why?
|
| Rotation | 1 | 2014 | 517 | 0.100 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2015 | 477 | 0.100 |
Why?
|
| Middle Aged | 20 | 2020 | 220895 | 0.100 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 450 | 0.100 |
Why?
|
| Mice, Knockout | 6 | 2007 | 14414 | 0.100 |
Why?
|
| Reflex | 2 | 2005 | 376 | 0.100 |
Why?
|
| Argon | 1 | 2011 | 36 | 0.100 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2014 | 307 | 0.100 |
Why?
|
| Liposarcoma | 1 | 2014 | 289 | 0.100 |
Why?
|
| Duodenum | 2 | 2012 | 490 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 11118 | 0.100 |
Why?
|
| Catheters | 1 | 2014 | 427 | 0.090 |
Why?
|
| Veterans | 2 | 2022 | 2647 | 0.090 |
Why?
|
| Genes, MHC Class I | 1 | 1992 | 235 | 0.090 |
Why?
|
| Gastroenterology | 1 | 2017 | 577 | 0.090 |
Why?
|
| Mice, Mutant Strains | 3 | 2008 | 1749 | 0.090 |
Why?
|
| Animals | 30 | 2023 | 168459 | 0.090 |
Why?
|
| Neoplasm Staging | 4 | 2015 | 11121 | 0.090 |
Why?
|
| NG-Nitroarginine Methyl Ester | 3 | 2008 | 260 | 0.090 |
Why?
|
| Demography | 1 | 2015 | 1648 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1347 | 0.090 |
Why?
|
| beta Catenin | 1 | 2015 | 1040 | 0.090 |
Why?
|
| Colon | 3 | 2009 | 1792 | 0.090 |
Why?
|
| Electric Stimulation | 3 | 2008 | 1736 | 0.080 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 247 | 0.080 |
Why?
|
| Aneuploidy | 1 | 2013 | 551 | 0.080 |
Why?
|
| Laser Coagulation | 1 | 2011 | 330 | 0.080 |
Why?
|
| Colitis | 3 | 2004 | 1233 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2019 | 5247 | 0.080 |
Why?
|
| World Health Organization | 1 | 2015 | 1322 | 0.080 |
Why?
|
| Mice | 24 | 2023 | 81525 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2015 | 1468 | 0.080 |
Why?
|
| Duodenogastric Reflux | 1 | 2008 | 4 | 0.080 |
Why?
|
| Life Style | 1 | 2020 | 3917 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 39106 | 0.080 |
Why?
|
| Pylorus | 1 | 2008 | 86 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 5305 | 0.070 |
Why?
|
| Endoscopes, Gastrointestinal | 1 | 2007 | 45 | 0.070 |
Why?
|
| Equipment Design | 3 | 2020 | 3510 | 0.070 |
Why?
|
| Deglutition | 3 | 2020 | 208 | 0.070 |
Why?
|
| Chick Embryo | 1 | 2009 | 982 | 0.070 |
Why?
|
| Watchful Waiting | 1 | 2011 | 491 | 0.070 |
Why?
|
| Coloring Agents | 1 | 2009 | 562 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 20098 | 0.070 |
Why?
|
| Cryosurgery | 1 | 2011 | 474 | 0.070 |
Why?
|
| Glycoproteins | 3 | 2008 | 2203 | 0.070 |
Why?
|
| Gastroparesis | 1 | 2008 | 136 | 0.070 |
Why?
|
| Intestine, Large | 1 | 2005 | 68 | 0.060 |
Why?
|
| Neuroendocrine Tumors | 1 | 2012 | 641 | 0.060 |
Why?
|
| Artifacts | 1 | 2014 | 1911 | 0.060 |
Why?
|
| Female | 22 | 2020 | 392644 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2019 | 8631 | 0.060 |
Why?
|
| Gastrectomy | 3 | 2018 | 672 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2803 | 0.060 |
Why?
|
| Neuromuscular Junction | 1 | 2007 | 405 | 0.060 |
Why?
|
| Paris | 2 | 2014 | 41 | 0.060 |
Why?
|
| Vagus Nerve | 2 | 2008 | 458 | 0.060 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 4575 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2009 | 1510 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12059 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 9 | 2008 | 22169 | 0.060 |
Why?
|
| Intestines | 2 | 2008 | 1909 | 0.060 |
Why?
|
| Quality of Life | 3 | 2023 | 13367 | 0.060 |
Why?
|
| Muscle, Smooth | 2 | 1999 | 926 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 1667 | 0.060 |
Why?
|
| Microscopy | 1 | 2009 | 903 | 0.060 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 2003 | 15 | 0.050 |
Why?
|
| Adult | 10 | 2019 | 221177 | 0.050 |
Why?
|
| Gene Targeting | 5 | 1997 | 838 | 0.050 |
Why?
|
| Arginine | 2 | 2005 | 934 | 0.050 |
Why?
|
| Anal Canal | 1 | 2005 | 373 | 0.050 |
Why?
|
| Chromosomal Instability | 1 | 2023 | 178 | 0.050 |
Why?
|
| Digestive System | 1 | 2003 | 244 | 0.050 |
Why?
|
| Video Recording | 1 | 2007 | 966 | 0.050 |
Why?
|
| Deoxyribonucleases | 1 | 2023 | 211 | 0.050 |
Why?
|
| Pressure | 1 | 2005 | 1154 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2014 | 9000 | 0.050 |
Why?
|
| Survival Rate | 3 | 2012 | 12725 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 14666 | 0.050 |
Why?
|
| Esophagoscopes | 1 | 2000 | 16 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2005 | 727 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 26125 | 0.050 |
Why?
|
| Disease Management | 1 | 2011 | 2508 | 0.050 |
Why?
|
| Base Sequence | 5 | 1996 | 12441 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 6935 | 0.040 |
Why?
|
| Esophageal Achalasia | 1 | 2001 | 94 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2005 | 1201 | 0.040 |
Why?
|
| Forecasting | 1 | 2009 | 2928 | 0.040 |
Why?
|
| Tyrosine | 1 | 2004 | 1440 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2009 | 3688 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2023 | 2825 | 0.040 |
Why?
|
| Desipramine | 1 | 2019 | 182 | 0.040 |
Why?
|
| Membrane Potentials | 2 | 2007 | 1090 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2005 | 1206 | 0.040 |
Why?
|
| Nitric Oxide Donors | 1 | 1999 | 125 | 0.040 |
Why?
|
| Baclofen | 1 | 2019 | 120 | 0.040 |
Why?
|
| Muscle Relaxants, Central | 1 | 2019 | 93 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2023 | 709 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 17635 | 0.040 |
Why?
|
| Tomography | 1 | 2000 | 411 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 6484 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2008 | 4003 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 12947 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2009 | 2827 | 0.040 |
Why?
|
| Adenoma | 1 | 2008 | 2160 | 0.040 |
Why?
|
| Vasodilation | 2 | 1999 | 962 | 0.040 |
Why?
|
| Gastrins | 1 | 1997 | 74 | 0.040 |
Why?
|
| Colonoscopy | 2 | 2020 | 1394 | 0.040 |
Why?
|
| Capsule Endoscopes | 1 | 2016 | 13 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3673 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2023 | 2510 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 12974 | 0.030 |
Why?
|
| Receptors, Muscarinic | 1 | 1997 | 157 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2012 | 4026 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 2017 | 290 | 0.030 |
Why?
|
| Conscious Sedation | 1 | 2020 | 532 | 0.030 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1996 | 180 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2015 | 12128 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 1996 | 256 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2018 | 80636 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1995 | 149 | 0.030 |
Why?
|
| Optic Chiasm | 1 | 1995 | 91 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2023 | 2932 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2023 | 1886 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2005 | 2598 | 0.030 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 1996 | 362 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 1995 | 621 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 1999 | 933 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 1996 | 564 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 2 | 1987 | 870 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2019 | 1596 | 0.030 |
Why?
|
| Fiducial Markers | 1 | 2014 | 132 | 0.030 |
Why?
|
| Nervous System | 1 | 1996 | 545 | 0.030 |
Why?
|
| Reference Values | 1 | 2000 | 4920 | 0.030 |
Why?
|
| Calcium Channels | 1 | 1997 | 620 | 0.030 |
Why?
|
| Genes | 2 | 1995 | 1823 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2000 | 5035 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 1995 | 13446 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 17904 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 951 | 0.030 |
Why?
|
| Age Factors | 1 | 2009 | 18395 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2014 | 469 | 0.030 |
Why?
|
| Body Patterning | 1 | 1996 | 632 | 0.020 |
Why?
|
| Antigens, Surface | 3 | 1990 | 1606 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 1995 | 3702 | 0.020 |
Why?
|
| Esophagitis | 1 | 2013 | 164 | 0.020 |
Why?
|
| Muscle Tonus | 1 | 2011 | 82 | 0.020 |
Why?
|
| Risk Factors | 4 | 2018 | 74206 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1995 | 2265 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 2748 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1995 | 2180 | 0.020 |
Why?
|
| Gene Expression | 2 | 1995 | 7581 | 0.020 |
Why?
|
| Esophagectomy | 1 | 2014 | 468 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1996 | 1989 | 0.020 |
Why?
|
| Leukemia, T-Cell | 1 | 1989 | 101 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6310 | 0.020 |
Why?
|
| Helicobacter pylori | 1 | 2013 | 377 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2015 | 12463 | 0.020 |
Why?
|
| Helicobacter Infections | 1 | 2013 | 388 | 0.020 |
Why?
|
| Mass Screening | 1 | 2005 | 5428 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2880 | 0.020 |
Why?
|
| Bezoars | 1 | 2008 | 29 | 0.020 |
Why?
|
| Apamin | 1 | 2007 | 17 | 0.020 |
Why?
|
| Time Factors | 2 | 2012 | 39967 | 0.020 |
Why?
|
| Mental Health | 1 | 2022 | 3250 | 0.020 |
Why?
|
| Models, Neurological | 1 | 1996 | 1767 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 1989 | 370 | 0.020 |
Why?
|
| Logistic Models | 2 | 2015 | 13255 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 7390 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 3 | 1992 | 6216 | 0.020 |
Why?
|
| Bile | 1 | 2008 | 298 | 0.020 |
Why?
|
| Genomics | 1 | 2023 | 5821 | 0.020 |
Why?
|
| Axons | 1 | 1995 | 1674 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 6534 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 16981 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 2578 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1996 | 2568 | 0.020 |
Why?
|
| Transfection | 2 | 1990 | 5774 | 0.020 |
Why?
|
| Phenotype | 4 | 2011 | 16591 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2007 | 1262 | 0.010 |
Why?
|
| Cell Movement | 1 | 1996 | 5203 | 0.010 |
Why?
|
| Bacterial Translocation | 1 | 2004 | 73 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1989 | 1745 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2004 | 221 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3595 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15266 | 0.010 |
Why?
|
| Myocardium | 1 | 1997 | 4726 | 0.010 |
Why?
|
| Retina | 1 | 1995 | 2659 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 1171 | 0.010 |
Why?
|
| Ganglia, Parasympathetic | 1 | 2003 | 18 | 0.010 |
Why?
|
| Heart | 1 | 1996 | 4404 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1995 | 4431 | 0.010 |
Why?
|
| Peristalsis | 1 | 2003 | 60 | 0.010 |
Why?
|
| Efferent Pathways | 1 | 2003 | 165 | 0.010 |
Why?
|
| Homozygote | 2 | 1997 | 1776 | 0.010 |
Why?
|
| Goblet Cells | 1 | 2004 | 298 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 2561 | 0.010 |
Why?
|
| Peroxidase | 1 | 2004 | 609 | 0.010 |
Why?
|
| Kidney | 1 | 1996 | 7048 | 0.010 |
Why?
|
| Sex Factors | 1 | 2014 | 10552 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2015 | 4486 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1995 | 12795 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1995 | 8481 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2004 | 1596 | 0.010 |
Why?
|
| Inflammation | 1 | 1999 | 10773 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2015 | 7967 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1986 | 1349 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2004 | 1687 | 0.010 |
Why?
|
| Parietal Cells, Gastric | 1 | 1997 | 44 | 0.010 |
Why?
|
| Motor Neurons | 1 | 2003 | 870 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 3712 | 0.010 |
Why?
|
| Mutation | 4 | 1996 | 30052 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1989 | 3617 | 0.010 |
Why?
|
| Gastric Acid | 1 | 1997 | 99 | 0.010 |
Why?
|
| Massachusetts | 1 | 2010 | 8830 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1997 | 311 | 0.010 |
Why?
|
| Diet | 1 | 2015 | 8075 | 0.010 |
Why?
|
| Semaphorin-3A | 1 | 1996 | 39 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1997 | 395 | 0.010 |
Why?
|
| Atropine | 1 | 1997 | 244 | 0.010 |
Why?
|
| Carbachol | 1 | 1997 | 223 | 0.010 |
Why?
|
| Carbocyanines | 1 | 1997 | 175 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2009 | 1922 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4575 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1997 | 777 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1996 | 851 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1981 | 1328 | 0.010 |
Why?
|
| Leukocytes | 1 | 2004 | 2026 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 1997 | 242 | 0.010 |
Why?
|
| Hypertension | 1 | 1995 | 8540 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 8002 | 0.010 |
Why?
|
| GAP-43 Protein | 1 | 1995 | 152 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 15732 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1996 | 325 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1997 | 629 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 14605 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 1997 | 927 | 0.010 |
Why?
|
| Nervous System Malformations | 1 | 1996 | 244 | 0.010 |
Why?
|
| Urine | 1 | 1996 | 362 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1990 | 4174 | 0.010 |
Why?
|
| Algorithms | 1 | 2014 | 14031 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 2726 | 0.010 |
Why?
|
| Chimera | 1 | 1995 | 453 | 0.010 |
Why?
|
| Cell Line | 3 | 1996 | 15601 | 0.010 |
Why?
|
| Trigeminal Nerve | 1 | 1995 | 248 | 0.010 |
Why?
|
| Optic Nerve | 1 | 1997 | 572 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5869 | 0.010 |
Why?
|
| Atrophy | 1 | 1997 | 1633 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 1995 | 526 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2012 | 23995 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1997 | 18965 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1995 | 1519 | 0.010 |
Why?
|
| Cell Division | 1 | 1997 | 4465 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 29625 | 0.010 |
Why?
|
| Heterozygote | 1 | 1996 | 2787 | 0.010 |
Why?
|
| Fetus | 1 | 1996 | 1863 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1989 | 814 | 0.000 |
Why?
|
| Retinal Ganglion Cells | 1 | 1995 | 811 | 0.000 |
Why?
|
| Aorta | 1 | 1995 | 2042 | 0.000 |
Why?
|
| Protein Conformation | 2 | 1987 | 3968 | 0.000 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1990 | 1351 | 0.000 |
Why?
|
| Mice, Inbred A | 1 | 1986 | 246 | 0.000 |
Why?
|
| Gene Expression Regulation | 2 | 1997 | 11903 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1986 | 1058 | 0.000 |
Why?
|
| Homeostasis | 1 | 1995 | 3323 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1997 | 9539 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1981 | 10194 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1997 | 6377 | 0.000 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1990 | 1784 | 0.000 |
Why?
|
| Signal Transduction | 2 | 1997 | 23445 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1989 | 3810 | 0.000 |
Why?
|
| Neoplasms, Experimental | 1 | 1987 | 1229 | 0.000 |
Why?
|
| beta 2-Microglobulin | 1 | 1981 | 329 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1990 | 4141 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1981 | 510 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1981 | 2186 | 0.000 |
Why?
|
| Antigens, Neoplasm | 1 | 1987 | 1993 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1981 | 1434 | 0.000 |
Why?
|
| Clone Cells | 1 | 1981 | 1659 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1995 | 11528 | 0.000 |
Why?
|
| Alleles | 1 | 1986 | 6863 | 0.000 |
Why?
|
| Epitopes | 1 | 1981 | 2503 | 0.000 |
Why?
|
| Genetic Variation | 1 | 1987 | 6567 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1987 | 9177 | 0.000 |
Why?
|